While generative AI models can hallucinate with low stakes, industrial AI cannot afford errors. This has created a premium for companies with unique, real-world datasets that are verifiable and critical for high-stakes decisions where failure could be catastrophic, like an explosion.

Snowflake's CEO rejects a "YOLO AI" approach where model outputs are unpredictable. He insists enterprise AI products must be trustworthy, treating their development with the same discipline as software engineering. This includes mandatory evaluations (evals) for every model change to ensure reliability.

A fundamental divide exists between consumer and enterprise AI. While consumer products often reward novelty and creativity, enterprise applications are worthless without correctness. This requires building systems grounded in truth that can extract what is verifiably correct from complex organizations.

Elicit built a Domain-Specific Language (DSL) defining reasoning primitives as microservices. Frontier models orchestrate these primitives to create structured workflows, ensuring complex processes run exactly as defined and overcoming the inherent unreliability of standard LLMs for high-stakes tasks.

While businesses accept that employees make mistakes, their expectation for software is absolute reliability. This unforgiving standard creates a durable moat for enterprise platforms that provide deterministic outcomes, a key challenge for probabilistic AI models in critical workflows.

For critical enterprise functions like financial modeling, 99.9% accuracy from a probabilistic LLM is unacceptable. Platforms like Salesforce's Agent Force 360 solve this by layering deterministic logic and guardrails on top of the AI, ensuring compliance and preventing costly errors where even a 0.1% failure rate is too high.

Unlike consumer chatbots, AlphaSense's AI is designed for verification in high-stakes environments. The UI makes it easy to see the source documents for every claim in a generated summary. This focus on traceable citations is crucial for building the user confidence required for multi-billion dollar decisions.

The competitive advantage in pharma isn't the sophistication of an AI algorithm, which is often a commodity built on third-party models. The true differentiator is the quality, relevance, and end-to-end consistency of the proprietary data used to train and validate these models. Poor data invalidates even the best analytics.

In high-stakes fields like healthcare, the cost of an AI error is immense. Product leaders must prioritize safety, reliability, and the reproducibility of outcomes. A complete audit trail is non-negotiable, as it enables the reversal of incorrect decisions and ensures accountability.